Featured Research

from universities, journals, and other organizations

Guidance molecules: New therapy shows novel therapeutic approach to fighting inflammation

Date:
April 9, 2011
Source:
Charité - Universitätsmedizin Berlin
Summary:
Researchers in Germany have succeeded in finding a new therapeutic approach to certain inflammatory reactions of the body. The approach focuses on guidance molecules, which reduce the body's own immune system to the required level and prevent excessive and damaging inflammation. Possible applications include therapies for inflammation, such as blood poisoning, but also in chronic inflammation and immunological inflammations such as rheumatoid arthritis and organ rejection.

Researchers at Charité – Universitätsmedizin Berlin have succeeded in finding a new therapeutic approach to certain inflammatory reactions of the body. The new approach, developed under the leadership of Prof. Dr. Schwab, focuses on guidance molecules, which reduce the body's own immune system to the required level and prevent excessive and damaging inflammation. Possible applications include therapies for inflammation, such as blood poisoning, but also in chronic inflammation and immunological inflammations such as rheumatoid arthritis and organ rejection.

Related Articles


Two types of guidance molecules, the attractive and the repulsive, direct the growth of nerve cells to the actual target. The designation of these molecules ("guidance" molecules) also describes the exclusive function that was previously attributed to them, namely to show the growing nerve fibers the way. The fundamentally new approach to the research of Prof. Dr. Schwab and his team at the Berlin-Brandenburg Center for Regenerative Therapies (BCRT) is the realization that these guidance molecules have an additional hitherto unknown role in the immune system.

The problem with the so-called "excessive" inflammation of the body is that the immune system overreacts and there by aggravates the actual inflammation.  Here the repulsive molecules drive the immune molecules (leukocytes) into the way and thus prevent the inflammation from getting out of control or becoming chronic. The research is published in the current issue of the journal Proceedings of the National Academy of Sciences.

The new approach represents a softer, more specific alternative to the orthodox approaches to the combat of inflammation such as cortisone, due to cortisone’s non-specific effect as well as many associated side effects which pose problems for many patients. Prof. Dr. Schwab is optimistic that through this research, a new effective therapy could be found, which can be effective in the fight against excessive inflammation; due to their fundamentally new understanding of this important aspect of the immune system.


Story Source:

The above story is based on materials provided by Charité - Universitätsmedizin Berlin. Note: Materials may be edited for content and length.


Journal Reference:

  1. V. Mirakaj, S. Brown, S. Laucher, C. Steinl, G. Klein, D. Kohler, T. Skutella, C. Meisel, B. Brommer, P. Rosenberger, J. M. Schwab. Repulsive guidance molecule-A (RGM-A) inhibits leukocyte migration and mitigates inflammation. Proceedings of the National Academy of Sciences, 2011; DOI: 10.1073/pnas.1015605108

Cite This Page:

Charité - Universitätsmedizin Berlin. "Guidance molecules: New therapy shows novel therapeutic approach to fighting inflammation." ScienceDaily. ScienceDaily, 9 April 2011. <www.sciencedaily.com/releases/2011/04/110407093234.htm>.
Charité - Universitätsmedizin Berlin. (2011, April 9). Guidance molecules: New therapy shows novel therapeutic approach to fighting inflammation. ScienceDaily. Retrieved November 25, 2014 from www.sciencedaily.com/releases/2011/04/110407093234.htm
Charité - Universitätsmedizin Berlin. "Guidance molecules: New therapy shows novel therapeutic approach to fighting inflammation." ScienceDaily. www.sciencedaily.com/releases/2011/04/110407093234.htm (accessed November 25, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Tuesday, November 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

Newsy (Nov. 25, 2014) — The US FDA is announcing new calorie rules on Tuesday that will require everywhere from theaters to vending machines to include calorie counts. Video provided by Newsy
Powered by NewsLook.com
Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Newsy (Nov. 25, 2014) — Need another reason to eat yogurt every day? Researchers now say it could reduce a person's risk of developing type 2 diabetes. Video provided by Newsy
Powered by NewsLook.com
Madagascar Working to Contain Plague Outbreak

Madagascar Working to Contain Plague Outbreak

AFP (Nov. 24, 2014) — Madagascar said Monday it is trying to contain an outbreak of plague -- similar to the Black Death that swept Medieval Europe -- that has killed 40 people and is spreading to the capital Antananarivo. Duration: 00:42 Video provided by AFP
Powered by NewsLook.com
Are Female Bosses More Likely To Be Depressed?

Are Female Bosses More Likely To Be Depressed?

Newsy (Nov. 24, 2014) — A new study links greater authority with increased depressive symptoms among women in the workplace. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins